| 产品详情 |
| Edit |   |
|---|
| Product Name | KX2-391 |
|---|
| Description | Purity 98%. KX2-391, the first clinical Src inhibitor (peptidomimetic class) that targets the peptide substrate site of Src, with GI50 of 9-60 nM in cancer cell lines. Phase 2. |
|---|
| Size | 2 mg, 5 mg, 1ml/10mM (In DMSO), 10 mg, 25 mg |
|---|
| Concentration | n/a |
|---|
| Applications | n/a |
|---|
| Other Names | n/a |
|---|
| Gene, Accession, CAS # | CAS: 897016-82-9 |
|---|
| Catalog # | MBS578896 |
|---|
| Price | |
|---|
| Order / More Info | KX2-391 from MYBIOSOURCE INC. |
|---|
| Product Specific References | n/a |
|---|
| 产品资料 |
|
|